Literature DB >> 22269289

Is obesity a new risk factor for gastritis?

Shunsuke Yamamoto1, Kenji Watabe, Tetsuo Takehara.   

Abstract

Obesity has become a major concern among gastroenterologists due to its large influence on gastrointestinal and hepatic diseases: reflux esophagitis, pancreatitis, gallstone disease, liver fibrosis, and neoplastic tumors of the esophagus, pancreas, and colon. Studies of morbid obese subjects undergoing bariatric surgery have revealed that obesity is related with an increased prevalence of endoscopic and histologic gastritis. A recent study of health check-up subjects demonstrated an association of obesity with endoscopic gastritis and gastric ulcers. We recently investigated the underlying mechanisms of the effects of obesity on endoscopic gastritis in subjects undergoing health check-up examination, and demonstrated that adiponectin, a bioactive molecule released from visceral fat, could be a protective factor of endoscopic gastritis. We would like to propose a new category of gastritis, obesity-related gastritis, which could become dominant in the near future.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269289     DOI: 10.1159/000334680

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  15 in total

Review 1.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

Review 2.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

Review 3.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

4.  Histopathological Findings in Morbid Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: Does H. pylori Infection Effective on Pathological Changes?

Authors:  Ramazan İlyas Öner; Sabri Özdaş
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

5.  What Does the Excised Stomach from Sleeve Gastrectomy Tell us?

Authors:  Melanie Lauti; Sophie E Gormack; Jeni M Thomas; Jon J Morrow; Habib Rahman; Andrew D MacCormick
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

Review 6.  Influence of metabolic syndrome on upper gastrointestinal disease.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Tetsuo Kimura; Koichi Okamoto; Hiroshi Miyamoto; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-07-02

7.  Gastric Histopathologic Findings in South Italian Morbidly Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy: Is Histopathologic Examination of All Resected Gastric Specimens Necessary?

Authors:  Iman Komaei; Giuseppe Currò; Federica Mento; Gabriele Cassaro; Claudio Lazzara; Adalberto Barbera; Michele Ammendola; Angela Alibrandi; Giuseppe Navarra
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

8.  Gastric histopathologies in patients undergoing laparoscopic sleeve gastrectomies.

Authors:  Sulaiman Almazeedi; Salman Al-Sabah; Ahmed Al-Mulla; Ahmed Al-Murad; Abdulsamad Al-Mossawi; Khaled Al-Enezi; Talib Jumaa; Waleed Bastaki
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

9.  AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.

Authors:  Hubert Zatorski; Maciej Salaga; Marta Zielińska; Kinga Majchrzak; Agata Binienda; Radzisław Kordek; Ewa Małecka-Panas; Jakub Fichna
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

10.  Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice.

Authors:  Kyoko Inagaki-Ohara; Shiki Okamoto; Kazuyo Takagi; Kumiko Saito; Seiya Arita; Lijun Tang; Tetsuji Hori; Hiroaki Kataoka; Satoshi Matsumoto; Yasuhiko Minokoshi
Journal:  Nutr Metab (Lond)       Date:  2016-02-02       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.